RxP director Allan Coukell addresses FDA Transparency Task Force

06/24/2009

Pew Prescription Project Director Allan Coukell addresses the FDA Transparency Task Force today. The agency announced the task force earlier this month as an effort to determine what sort of information it should release to the public, and when.

Mr Coukell's comments were given on behalf of a group of noted drug safety experts, researchers, and medical ethicists, including: Professor Jerry Avorn of Harvard Medical School, Dr Aaron Kesselheim of Harvard Medical School; Dr Steven Nissen of the Cleveland Clinic; Bruce M. Psaty, MD, PhD of University of Washington (Seattle); Dr Joseph Ross, Mt Sinai School of Medicine; Dr Erick Turner, Oregon Health & Science University; Kay Dickersin, MA, PhD, Johns Hopkins Bloomberg School of Public Health and US Cochrane Center; Professor Art Caplan, University of Pennsylvania; Dr Howard Mann, University of Utah; and Karen Maschke, PhD, The Hastings Center.